Acrinova AB Series B (ACRI-B) — Capital Reinvestment Ratio
Latest as of March 2026:
1.00x
Acrinova AB Series B (ACRI-B) has a Capital Reinvestment Ratio of 1.00x as of March 2026, meaning it reinvests 1% of its operating cash flow (Skr51.65 Million) in capital expenditures (Skr51.65 Million). See Acrinova AB Series B free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
1.00x
Capex / Operating Cash Flow
Operating Cash Flow
Skr51.65 Million
SEK
Capital Expenditures
Skr51.65 Million
SEK
Data as of
Mar 2026
Most recent filing
Acrinova AB Series B Capital Reinvestment Ratio (2014–2025)
This chart tracks Acrinova AB Series B's Capital Reinvestment Ratio across 10 annual periods.
Annual Capital Reinvestment Ratio for Acrinova AB Series B (2014–2025)
Year-by-year Capital Reinvestment Ratio for Acrinova AB Series B from 2014 to 2025. For live market cap and broader valuation context, see ACRI-B market cap.
| Year | Reinvestment Ratio | Operating CF (SEK) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 1.00x | Skr337.73 Million | Skr337.73 Million | ▲ +25.8% |
| 2024 | 0.79x | Skr61.06 Million | Skr48.53 Million | ▼ -62.0% |
| 2023 | 2.09x | Skr71.23 Million | Skr148.92 Million | ▲ +1713.8% |
| 2021 | 0.12x | Skr79.90 Million | Skr9.21 Million | ▲ +55.3% |
| 2020 | 0.07x | Skr33.98 Million | Skr2.52 Million | ▼ -44.0% |
| 2019 | 0.13x | Skr10.57 Million | Skr1.40 Million | ▲ +44.4% |
| 2018 | 0.09x | Skr15.26 Million | Skr1.40 Million | ▲ +264.2% |
| 2017 | 0.03x | Skr25.46 Million | Skr642.00K | ▼ -74.3% |
| 2016 | 0.10x | Skr16.52 Million | Skr1.62 Million | ▼ -91.5% |
| 2014 | 1.16x | Skr41.33 Million | Skr47.85 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow